U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

Cover of StatPearls

StatPearls [Internet].

Show details

Physiology, Postpartum Changes

; .

Author Information and Affiliations

Last Update: June 17, 2026.

Introduction

The postpartum period, also known as the puerperium, begins immediately after delivery of the placenta and represents a time of significant physiologic adaptation as the maternal body transitions back toward its nonpregnant state. This period is generally considered to last approximately 6 weeks, although some physiologic adaptations may continue beyond that timeframe. During this time, multiple organ systems undergo coordinated and dynamic changes.

The uterus gradually returns to its prepregnancy size through a process of involution, while cardiovascular and hematologic systems adjust to rapid shifts in intravascular volume and fluid balance following delivery. Hormonal changes following placental delivery, particularly the rapid decline in estrogen and progesterone, facilitate the initiation of lactation via prolactin and oxytocin signaling pathways. Understanding these normal postpartum adaptations is essential for distinguishing expected physiologic recovery from pathologic conditions that may arise during this period.[1][2] 

Organ Systems Involved

General Physiological Changes

Immediately after delivery, women commonly experience generalized fatigue related to the physical demands of labor and delivery, as well as sleep disruption and psychosocial stressors in the early postpartum period.[3] Maternal vital signs may show transient changes in the early postpartum period. The pulse rate can be mildly elevated during the first several hours after childbirth, often related to pain, exertion, or emotional stress, and typically returns to baseline by the second postpartum day. Blood pressure generally remains within the normal range but may be transiently elevated due to pain or anxiety.[4] A significant decrease in blood pressure should raise concern for complications, eg, postpartum hemorrhage or sepsis, while persistent hypertension warrants evaluation for hypertensive disorders of pregnancy.[4][5][6]

Body temperature may rise slightly during the first 24 hours after delivery, sometimes accompanied by shivering, diaphoresis, or chills, and usually normalizes within the first day postpartum.[4] A small transient increase in temperature can also occur several days after delivery in association with breast engorgement.[5] Respiratory rate typically returns to prepregnancy levels within the first few days following delivery. In addition, women commonly experience a reduction in body weight immediately after birth due to the delivery of the fetus, placenta, and amniotic fluid, followed by additional weight loss over the subsequent days from postpartum diuresis and mobilization of extracellular fluid.[7]

Reproductive

Involution refers to the process by which the reproductive organs return to their prepregnancy state following delivery. Immediately after childbirth, the uterus contracts to compress uterine blood vessels at the placental site and reduce postpartum blood loss. At this stage, the uterus is firm and weighs approximately 1000 g. Rapid uterine involution occurs during the first postpartum week, with the uterine weight decreasing to approximately 500 gm by the end of the first week and returning to near its prepregnancy weight of about 50 to 100 g within approximately 6 weeks.[8][9] This reduction in uterine size occurs through myometrial cell contraction, autolysis of hypertrophied muscle fibers, and remodeling of the uterine vasculature. Hormonal withdrawal following delivery, particularly the rapid decline in estrogen and progesterone levels, facilitates activation of proteolytic enzymes and tissue remodeling that support uterine involution.[10][11][12] 

During the postpartum period, vaginal discharge, known as lochia, originates from the uterus, cervix, and vagina. Lochia typically progresses through 3 stages. Lochia rubra is observed during the first several days postpartum, consisting primarily of blood and decidual debris. Lochia serosa is seen during the following days and is characterized by a pink or brown discharge containing leukocytes and mucus. Lochia alba, a whitish discharge, follows and may persist for several weeks. Lochia may continue for up to 4 to 6 weeks postpartum. Persistence of red lochia beyond the first week may suggest uterine subinvolution.[13][14] The cervix and vagina are often edematous and may appear bruised in the early postpartum period, but they gradually heal over several weeks. Vaginal tone progressively returns as ovarian function resumes, although restoration of the vaginal epithelium may be delayed in breastfeeding individuals due to a hypoestrogenic state associated with lactation.[15][16][17]

Lactation

Colostrum, the initial breast secretion produced after childbirth, is rich in protein, vitamins, immunoglobulins (particularly secretory IgA), and antimicrobial factors such as lactoferrin, providing important immunologic protection to the newborn.[18] Mammogenesis, or preparation of the breasts for lactation, begins during pregnancy and involves ductal and lobuloalveolar hyperplasia and hypertrophy under the influence of estrogen and progesterone.[19] Despite elevated prolactin levels during pregnancy, the high concentrations of estrogen and progesterone inhibit its secretory action. Following delivery, the rapid decline in these hormones permits prolactin to stimulate milk synthesis within the mammary glands, marking the onset of lactogenesis, which typically occurs 48 to 96 hours postpartum.[20]

The neuroendocrine reflex of lactation is initiated by suckling, which generates afferent impulses from the nipple-areolar complex that travel via thoracic sensory pathways to the hypothalamus. This stimulates the paraventricular and supraoptic nuclei, resulting in oxytocin release from the posterior pituitary. Oxytocin induces contraction of myoepithelial cells, leading to milk ejection, also known as the let-down reflex.[21] This reflex may be inhibited by pain, stress, anxiety, or breast engorgement, as psychosocial stressors can disrupt hormonal regulation of lactation.[22] 

Prolactin, secreted by the anterior pituitary, is responsible for galactopoiesis, or the maintenance of ongoing milk production, which is regulated by a supply and demand mechanism dependent on effective milk removal.[21] A healthy lactating woman typically produces approximately 600 to 900 mL of milk per day. Lactation increases maternal energy requirements by approximately 450 to 500 kcal per day, reflecting the metabolic demands of milk synthesis and nutrient transfer, and may be partially supported by fat stores accumulated during pregnancy.[21][18] Common complications during this period include nipple soreness and mastitis, which may represent a spectrum of breast inflammation with or without infection.[23] 

Endocrine

The timing of the first menstrual period following delivery is variable and is strongly influenced by lactation status. In nonlactating women, ovulation and menstrual function typically resume within 6 to 8 weeks postpartum.[24][25] In contrast, lactation is associated with suppression of ovulation due to elevated prolactin levels stimulated by suckling. Prolactin inhibits hypothalamic gonadotropin-releasing hormone secretion, thereby reducing follicle-stimulating hormone and luteinizing hormone release and suppressing ovarian follicular development.[26][27] 

The duration of anovulation correlates with the frequency and intensity of breastfeeding. This physiologic suppression forms the basis of the lactational amenorrhea method, which can provide effective contraception under specific conditions. In lactating women, the return of menstruation is variable and may occur within several months postpartum or be delayed for over a year, depending on breastfeeding patterns.[28] However, ovulation may precede the first menstrual period, and pregnancy can occur in the absence of menses.[29] Therefore, appropriate contraceptive counseling is essential in the postpartum period.

Following delivery, levels of human chorionic gonadotropin decline rapidly. Thyroid gland size typically returns to its prepregnancy state within several weeks to months, and thyroid function generally normalizes during this period.[30] In the postpartum period, thyroid physiology is influenced not only by the decline in pregnancy-related hormones but also by immune reconstitution after the relatively immunosuppressed state of pregnancy. While pregnancy promotes immune tolerance, the postpartum period is marked by a rebound in immune activity, which can transiently affect thyroid function before returning to baseline.[31] The diabetogenic state of pregnancy resolves after delivery due to the abrupt decline in placental hormones. Insulin sensitivity improves rapidly, although normalization may be delayed in patients with obesity or underlying insulin resistance.[32][33]

Renal

Following delivery, the bladder wall may become edematous and hyperemic, and bladder overdistention can occur with diminished sensation to void. Postpartum urinary retention in the early puerperium is multifactorial and may result from decreased detrusor contractility, pelvic floor trauma, regional anesthesia, periurethral edema, or reflex inhibition of micturition following genitourinary injury.[34][35] Urinary incontinence is also common in the postpartum period, affecting a significant proportion of women, with stress and urge incontinence being the most frequently reported types. This is primarily attributed to pelvic floor muscle injury, connective tissue damage, and neurologic impairment related to pregnancy and vaginal delivery rather than psychological factors alone.[36] 

Patients may report dysuria or painful micturition, often related to perineal trauma, lacerations, or episiotomy. During pregnancy, mechanical compression from the gravid uterus and progesterone-mediated smooth muscle relaxation lead to ureteral dilation, decreased peristalsis, and increased renal pelvic volume.[37] These physiologic changes may persist into the postpartum period but typically resolve within 4 to 8 weeks. Urinary stasis during pregnancy and the early postpartum period contributes to an increased risk of urinary tract infections. Postpartum patients should be encouraged to void regularly, typically every 3 to 4 hours, to reduce the risk of bladder overdistention and associated complications.[35] 

Fluids

During the postpartum period, fluid shifts from the extravascular to the intravascular space, reflecting mobilization of the expanded plasma volume accumulated during pregnancy.[7] Pregnancy is associated with activation of the renin-angiotensin-aldosterone system, resulting in increased total body sodium and water retention.[7][38] 

Following delivery, increased levels of atrial natriuretic peptide and a decline in aldosterone and vasopressin activity promote natriuresis and diuresis.[39][40] This results in a period of brisk diuresis in the early postpartum phase, particularly within the first 1 to 2 weeks, with increased urine output that helps eliminate excess fluid retained during pregnancy. Renal function gradually returns to the prepregnancy state, with normalization of glomerular filtration rate occurring over several weeks postpartum. Transient lactosuria may be observed during the early days of lactation due to increased lactose production and excretion.[41] 

Hematologic

Hematologic changes in the postpartum period reflect both blood loss at delivery and ongoing fluid shifts. Hematocrit may initially decrease due to peripartum blood loss but subsequently rises with postpartum diuresis and hemoconcentration. Variability in hemoglobin and hematocrit values during this period is largely due to dynamic changes in plasma volume. Over time, hemoglobin gradually returns to prepregnancy levels, although complete resolution of pregnancy-associated hemodilution may take several months postpartum.[42]

Leukocytosis is common in the immediate postpartum period as a physiologic response to labor and stress, which may reach markedly elevated levels before returning to baseline within several weeks. Gestational thrombocytopenia typically resolves after delivery, with platelet counts increasing over the first 1 to 2 weeks postpartum.[43] Pregnancy is characterized by a hypercoagulable state, with increased levels of fibrinogen, clotting factors VII, VIII, X, and von Willebrand factor, along with decreased fibrinolytic activity.[44]

In the early postpartum period, many of these procoagulant changes persist, with elevated fibrinogen levels and rising platelet counts, while fibrinolysis remains relatively suppressed. These changes gradually normalize over several weeks postpartum. As a result, the risk of thromboembolic events remains significantly elevated in the postpartum period, particularly in the first several weeks following delivery.[45] Laboratory markers such as D-dimer and fibrin degradation products may remain elevated, making them less reliable for diagnosing thromboembolism in the immediate postpartum setting.[46]

Cardiovascular

Significant structural and hemodynamic changes occur during the peripartum period. Cardiac output increases progressively throughout pregnancy, primarily due to increases in stroke volume and heart rate, with a peak in late pregnancy.[47][48] In the immediate postpartum period, a transient rise in circulating blood volume occurs due to uterine contractions and auto-transfusion, along with increased preload from relief of inferior vena cava compression. This results in a temporary increase in stroke volume and cardiac output immediately following delivery, followed by a rapid decline towards prepregnancy values over the subsequent days to weeks.

During pregnancy, elevated levels of progesterone and relaxin contribute to systemic vasodilation, leading to reduced systemic vascular resistance and a corresponding decrease in blood pressure, with a greater reduction in diastolic than in systolic pressure. These changes begin to reverse in late pregnancy and normalize gradually during the postpartum period.[49] Heart rate increases during pregnancy and returns to baseline over several weeks postpartum.

Pregnancy is associated with physiologic cardiac remodeling, including increases in left ventricular wall thickness, mass, and chamber size. These changes represent adaptive hypertrophy and typically regress after delivery, with gradual reverse remodeling occurring over weeks to months postpartum.[50] Cardiac contractility and ejection fraction are generally preserved throughout pregnancy and the postpartum period in healthy individuals.[48][49] 

Gastrointestinal

Hormonal changes, perineal discomfort, and altered bowel motility influence gastrointestinal function in the postpartum period. Postpartum constipation is common and is multifactorial, resulting from decreased gastrointestinal motility during pregnancy, perineal pain, hemorrhoids, dehydration, and reduced physical activity.[51] Progesterone-mediated smooth muscle relaxation during pregnancy contributes to decreased gastrointestinal transit, and normalization of bowel function may take several days after delivery.[52] 

Transient ileus may also occur in the immediate postpartum period, particularly following cesarean delivery, due to surgical stress, opioid use, and electrolyte imbalances.[53] Patients may experience abdominal bloating, flatulence, or delayed passage of stool during this time. During pregnancy, gastroesophageal reflux is common due to decreased lower esophageal sphincter tone and mechanical displacement of the stomach by the gravid uterus.[52][54][55] Following delivery, the decline in progesterone levels and relief of intra-abdominal pressure lead to improvement in reflux symptoms, typically within the first few days postpartum.[54]

Integumentary

Cutaneous changes are common during pregnancy and the postpartum period, with hyperpigmentation being among the most frequently reported findings, affecting the majority of pregnant women.[56] These changes are thought to result from increased levels of estrogen, progesterone, and melanocyte-stimulating activity, which enhance melanin production. Common manifestations include melasma and linea nigra, which typically improve gradually in the postpartum period, although complete resolution may take several months and may be incomplete in some individuals.[57] 

Elevated estrogen levels during pregnancy can also lead to vascular changes such as telangiectasias and spider angiomas, which generally regress after delivery.[58] Increased venous pressure and mechanical effects of the gravid uterus contribute to lower extremity edema and varicosities during pregnancy, which typically improve postpartum as venous return normalizes. Nail changes, including increased fragility, ridging, and mild pigmentation, may occur during pregnancy and usually resolve after delivery.[59] The abdominal wall undergoes significant stretching during pregnancy, and while muscle tone gradually improves postpartum, some patients may experience persistent diastasis recti. Striae gravidarum often fade over time, but typically do not completely resolve.[60] 

Clinical Significance

Human physiology is significantly altered during pregnancy and in the postpartum period. The clinician should understand the physiological changes associated with the postpartum period. The clinician should be able to differentiate between normal and abnormal findings to guide appropriate diagnostic and therapeutic decision-making, especially in cases of acute emergencies, eg, postpartum hemorrhage, sepsis, amniotic fluid embolism, or uterine inversion.

Furthermore, one should be aware of the hormonal changes related to the puerperium and lactation to develop an effective postpartum contraception plan. Thromboprophylaxis in the postpartum period is also a critical consideration due to the increased risk of venous thromboembolism; patients are typically risk-stratified into low-, intermediate-, and high-risk categories. Patients with no coagulation abnormalities or low-risk profiles generally do not require pharmacologic thromboprophylaxis. Intermediate risk patients may be considered for postpartum thromboprophylaxis for up to 7 days, while high risk patients often require thromboprophylaxis during pregnancy and extending into the postpartum period. The approach of anesthesia also varies according to the timing following delivery. Patients undergoing surgery under general anesthesia within 48 hours of delivery should be treated as having a full stomach and managed with aspiration precautions, including nonparticulate antacids and rapid sequence induction. 

The postpartum period is characterized by rapid and complex physiologic changes across multiple organ systems as the maternal body transitions from pregnancy to the nonpregnant state. Understanding these changes is clinically significant because many normal postpartum adaptations can mimic or mask serious pathology. Hemodynamic shifts, including mobilization of extravascular fluid and changes in cardiac output, may influence blood pressure management and contribute to complications, eg, pulmonary edema or delayed recognition of hemorrhage.

Endocrine fluctuations affect lactation, mood, glucose metabolism, and thyroid function, while hematologic changes sustain a transient hypercoagulable state, increasing the risk of venous thromboembolism. Uterine involution, pelvic floor recovery, and hormonal alterations also influence bleeding patterns, urinary and bowel function, sexual health, and breastfeeding success. Recognition of expected physiologic recovery versus warning signs of disease is essential for timely diagnosis, patient counseling, and prevention of maternal morbidity during the postpartum period.

Review Questions

References

1.
Romano M, Cacciatore A, Giordano R, La Rosa B. Postpartum period: three distinct but continuous phases. J Prenat Med. 2010 Apr;4(2):22-5. [PMC free article: PMC3279173] [PubMed: 22439056]
2.
Brown JS, Posner SF, Stewart AL. Urge incontinence: new health-related quality of life measures. J Am Geriatr Soc. 1999 Aug;47(8):980-8. [PubMed: 10443860]
3.
Baattaiah BA, Alharbi MD, Aldhahi MI, Khan F. Factors associated with postpartum fatigue: an exploration of the moderating role of resilience. Front Public Health. 2024;12:1394380. [PMC free article: PMC11211369] [PubMed: 38947349]
4.
Green LJ, Pullon R, Mackillop LH, Gerry S, Birks J, Salvi D, Davidson S, Loerup L, Tarassenko L, Mossop J, Edwards C, Gauntlett R, Harding K, Chappell LC, Knight M, Watkinson PJ. Postpartum-Specific Vital Sign Reference Ranges. Obstet Gynecol. 2021 Feb 01;137(2):295-304. [PMC free article: PMC7813441] [PubMed: 33417320]
5.
Rosenfeld EB, Buhmaid S, Vaseeharan A. Management of postpartum hypertension. Curr Opin Obstet Gynecol. 2026 Apr 01;38(2):72-77. [PubMed: 41531238]
6.
Woodd SL, Montoya A, Barreix M, Pi L, Calvert C, Rehman AM, Chou D, Campbell OMR. Incidence of maternal peripartum infection: A systematic review and meta-analysis. PLoS Med. 2019 Dec;16(12):e1002984. [PMC free article: PMC6903710] [PubMed: 31821329]
7.
Odutayo A, Hladunewich M. Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy. Clin J Am Soc Nephrol. 2012 Dec;7(12):2073-80. [PubMed: 22879432]
8.
Buisson P, Tomikowski J, Santarelli J, Kapitaniak B. [Clinical and ultrasonographic study of uterine involution in postpartum physiology]. Rev Fr Gynecol Obstet. 1993 Jan;88(1):12-8. [PubMed: 8441882]
9.
Kristoschek JH, Moreira de Sá RA, Silva FCD, Vellarde GC. Ultrasonographic Evaluation of Uterine Involution in the Early Puerperium. Rev Bras Ginecol Obstet. 2017 Apr;39(4):149-154. [PMC free article: PMC10309319] [PubMed: 28371959]
10.
Spooner MK, Lenis YY, Watson R, Jaimes D, Patterson AL. The role of stem cells in uterine involution. Reproduction. 2021 Mar;161(3):R61-R77. [PubMed: 33439148]
11.
Dessouky DA. Myometrical changes in postpartum uterine involution. Am J Obstet Gynecol. 1971 Jun 01;110(3):318-29. [PubMed: 5088369]
12.
Hamburg-Shields E, Mesiano S. The hormonal control of parturition. Physiol Rev. 2024 Jul 01;104(3):1121-1145. [PMC free article: PMC11380996] [PubMed: 38329421]
13.
Sherman D, Lurie S, Frenkel E, Kurzweil Y, Bukovsky I, Arieli S. Characteristics of normal lochia. Am J Perinatol. 1999;16(8):399-402. [PubMed: 10772198]
14.
Oppenheimer LW, Sherriff EA, Goodman JD, Shah D, James CE. The duration of lochia. Br J Obstet Gynaecol. 1986 Jul;93(7):754-7. [PubMed: 3755355]
15.
Perelmuter S, Burns R, Shearer K, Grant R, Soogoor A, Jun S, Meurer JA, Krapf J, Rubin R. Genitourinary syndrome of lactation: a new perspective on postpartum and lactation-related genitourinary symptoms. Sex Med Rev. 2024 Jun 26;12(3):279-287. [PubMed: 38757214]
16.
Lev-Sagie A, Amsalem H, Gutman Y, Esh-Broder E, Daum H. Prevalence and Characteristics of Postpartum Vulvovaginal Atrophy and Lack of Association With Postpartum Dyspareunia. J Low Genit Tract Dis. 2020 Oct;24(4):411-416. [PubMed: 32569019]
17.
Smith PE, McLaughlin EM, Pandya LK, Hade EM, Lynch CD, Hudson CO. A pilot randomized controlled trial of vaginal estrogen on postpartum atrophy, perineal pain, and sexual function. Int Urogynecol J. 2022 Dec;33(12):3383-3390. [PMC free article: PMC9020152] [PubMed: 35441854]
18.
Sabir S, Alhawaj AF. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Dec 14, 2025. Physiology, Breast Milk. [PubMed: 30969612]
19.
Katulski K, Katulski A, Nykowska A, Beutler K, Kozielek K, Antczak S, Katulska K. Physiological changes in the mammary glands during a female's life. Pol J Radiol. 2024;89:e386-e390. [PMC free article: PMC11384216] [PubMed: 39257924]
20.
Neville MC, Morton J. Physiology and endocrine changes underlying human lactogenesis II. J Nutr. 2001 Nov;131(11):3005S-8S. [PubMed: 11694636]
21.
Pados BF, Camp L. Physiology of Human Lactation and Strategies to Support Milk Supply for Breastfeeding. Nurs Womens Health. 2024 Aug;28(4):303-314. [PubMed: 38972331]
22.
Matyas M, Apanasewicz A, Krzystek-Korpacka M, Jamrozik N, Cierniak A, Babiszewska-Aksamit M, Ziomkiewicz A. The association between maternal stress and human milk concentrations of cortisol and prolactin. Sci Rep. 2024 Nov 15;14(1):28115. [PMC free article: PMC11568148] [PubMed: 39548101]
23.
Purkiewicz A, Regin KJ, Mumtaz W, Pietrzak-Fiećko R. Breastfeeding: The Multifaceted Impact on Child Development and Maternal Well-Being. Nutrients. 2025 Apr 11;17(8) [PMC free article: PMC12030032] [PubMed: 40284191]
24.
Jackson E, Glasier A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol. 2011 Mar;117(3):657-662. [PubMed: 21343770]
25.
McNeilly AS. Lactational control of reproduction. Reprod Fertil Dev. 2001;13(7-8):583-90. [PubMed: 11999309]
26.
Szukiewicz D. Current Insights in Prolactin Signaling and Ovulatory Function. Int J Mol Sci. 2024 Feb 06;25(4) [PMC free article: PMC10889014] [PubMed: 38396659]
27.
Hackwell ECR, Ladyman SR, Clarkson J, McQuillan HJ, Boehm U, Herbison AE, Brown RSE, Grattan DR. Prolactin-mediates a lactation-induced suppression of arcuate kisspeptin neuronal activity necessary for lactational infertility in mice. Elife. 2025 Jan 17;13 [PMC free article: PMC11741520] [PubMed: 39819370]
28.
Samejima A, Motoki N, Haga A, Tokutake C, Nakagomi S, Tsukahara T, Nomiyama T, Kanai M. The Current Status of Postpartum Menstrual Resumption Delay and Associated Risk Factors in Japanese Women: An Adjunct Study of the Japan Environment and Children's Study. Yonago Acta Med. 2024 Aug;67(3):201-212. [PMC free article: PMC11335921] [PubMed: 39176187]
29.
Bouchard T, Fehring RJ, Schneider M. Efficacy of a new postpartum transition protocol for avoiding pregnancy. J Am Board Fam Med. 2013 Jan-Feb;26(1):35-44. [PubMed: 23288279]
30.
Korevaar TIM, Medici M, Visser TJ, Peeters RP. Thyroid disease in pregnancy: new insights in diagnosis and clinical management. Nat Rev Endocrinol. 2017 Oct;13(10):610-622. [PubMed: 28776582]
31.
Ahn HY, Yi KH. Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum: 2023 Revised Korean Thyroid Association Guidelines. Endocrinol Metab (Seoul). 2023 Jun;38(3):289-294. [PMC free article: PMC10323161] [PubMed: 37291743]
32.
Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018 Oct 26;19(11) [PMC free article: PMC6274679] [PubMed: 30373146]
33.
Mora-Ortiz M, Rivas-García L. Gestational Diabetes Mellitus: Unveiling Maternal Health Dynamics from Pregnancy Through Postpartum Perspectives. Open Res Eur. 2024;4:164. [PMC free article: PMC11443192] [PubMed: 39355538]
34.
Mulder FE, Schoffelmeer MA, Hakvoort RA, Limpens J, Mol BW, van der Post JA, Roovers JP. Risk factors for postpartum urinary retention: a systematic review and meta-analysis. BJOG. 2012 Nov;119(12):1440-6. [PubMed: 22900796]
35.
Mohr S, Raio L, Gobrecht-Keller U, Imboden S, Mueller MD, Kuhn A. Postpartum urinary retention: what are the sequelae? A long-term study and review of the literature. Int Urogynecol J. 2022 Jun;33(6):1601-1608. [PMC free article: PMC9206615] [PubMed: 35129645]
36.
Tähtinen RM, Cartwright R, Tsui JF, Aaltonen RL, Aoki Y, Cárdenas JL, El Dib R, Joronen KM, Al Juaid S, Kalantan S, Kochana M, Kopec M, Lopes LC, Mirza E, Oksjoki SM, Pesonen JS, Valpas A, Wang L, Zhang Y, Heels-Ansdell D, Guyatt GH, Tikkinen KAO. Long-term Impact of Mode of Delivery on Stress Urinary Incontinence and Urgency Urinary Incontinence: A Systematic Review and Meta-analysis. Eur Urol. 2016 Jul;70(1):148-158. [PMC free article: PMC5009182] [PubMed: 26874810]
37.
Demiroğlu Ç, Solakhan M. Hydronephrosis in pregnancy: Critical factors determining urinary catheter use. Obstet Med. 2026 Mar;19(1):40-45. [PMC free article: PMC12187711] [PubMed: 40575579]
38.
Irani RA, Xia Y. Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol. 2011 Jan;31(1):47-58. [PMC free article: PMC3275085] [PubMed: 21266264]
39.
Cheung KL, Lafayette RA. Renal physiology of pregnancy. Adv Chronic Kidney Dis. 2013 May;20(3):209-14. [PMC free article: PMC4089195] [PubMed: 23928384]
40.
Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol. 2007 May;2(3):543-9. [PubMed: 17699462]
41.
Neville MC, Allen JC, Archer PC, Casey CE, Seacat J, Keller RP, Lutes V, Rasbach J, Neifert M. Studies in human lactation: milk volume and nutrient composition during weaning and lactogenesis. Am J Clin Nutr. 1991 Jul;54(1):81-92. [PubMed: 2058592]
42.
Milman N. Postpartum anemia I: definition, prevalence, causes, and consequences. Ann Hematol. 2011 Nov;90(11):1247-53. [PubMed: 21710167]
43.
Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, Vesely SK, George JN. Platelet Counts during Pregnancy. N Engl J Med. 2018 Jul 05;379(1):32-43. [PMC free article: PMC6049077] [PubMed: 29972751]
44.
James AH. Pregnancy-associated thrombosis. Hematology Am Soc Hematol Educ Program. 2009:277-85. [PubMed: 20008211]
45.
Sultan AA, West J, Tata LJ, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. Br J Haematol. 2012 Feb;156(3):366-73. [PubMed: 22145820]
46.
Chan WS, Lee A, Spencer FA, Chunilal S, Crowther M, Wu W, Johnston M, Rodger M, Ginsberg JS. D-dimer testing in pregnant patients: towards determining the next 'level' in the diagnosis of deep vein thrombosis. J Thromb Haemost. 2010 May;8(5):1004-11. [PubMed: 20128870]
47.
Meah VL, Cockcroft JR, Backx K, Shave R, Stöhr EJ. Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses. Heart. 2016 Apr;102(7):518-26. [PubMed: 26794234]
48.
Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation. 2014 Sep 16;130(12):1003-8. [PubMed: 25223771]
49.
Melchiorre K, Sharma R, Khalil A, Thilaganathan B. Maternal Cardiovascular Function in Normal Pregnancy: Evidence of Maladaptation to Chronic Volume Overload. Hypertension. 2016 Apr;67(4):754-62. [PubMed: 26962206]
50.
Collins HE, Alexander BT, Care AS, Davenport MH, Davidge ST, Eghbali M, Giussani DA, Hoes MF, Julian CG, LaVoie HA, Olfert IM, Ozanne SE, Bytautiene Prewit E, Warrington JP, Zhang L, Goulopoulou S. Guidelines for assessing maternal cardiovascular physiology during pregnancy and postpartum. Am J Physiol Heart Circ Physiol. 2024 Jul 01;327(1):H191-H220. [PMC free article: PMC11380979] [PubMed: 38758127]
51.
Salari N, Mohamadi S, Hemmati M, Fallahi A, Rasoulpoor S, Zarei H, Shohaimi S, Mohammadi M. Global prevalence of constipation during pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024 Dec 20;24(1):836. [PMC free article: PMC11660625] [PubMed: 39707279]
52.
Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am. 2003 Mar;32(1):235-61. [PubMed: 12635418]
53.
Vather R, O'Grady G, Bissett IP, Dinning PG. Postoperative ileus: mechanisms and future directions for research. Clin Exp Pharmacol Physiol. 2014 May;41(5):358-70. [PubMed: 24754527]
54.
Longo SA, Moore RC, Canzoneri BJ, Robichaux A. Gastrointestinal Conditions during Pregnancy. Clin Colon Rectal Surg. 2010 Jun;23(2):80-9. [PMC free article: PMC2967327] [PubMed: 21629625]
55.
Ali RAR, Hassan J, Egan LJ. Review of recent evidence on the management of heartburn in pregnant and breastfeeding women. BMC Gastroenterol. 2022 May 04;22(1):219. [PMC free article: PMC9066781] [PubMed: 35508989]
56.
Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol. 2001 Jul;45(1):1-19; quiz 19-22. [PubMed: 11423829]
57.
Bieber AK, Martires KJ, Stein JA, Grant-Kels JM, Driscoll MS, Pomeranz MK. Pigmentation and Pregnancy: Knowing What Is Normal. Obstet Gynecol. 2017 Jan;129(1):168-173. [PubMed: 27926637]
58.
Gupta SN, Madke B, Ganjre S, Jawade S, Kondalkar A. Cutaneous Changes During Pregnancy: A Comprehensive Review. Cureus. 2024 Sep;16(9):e69986. [PMC free article: PMC11497768] [PubMed: 39445254]
59.
Matushansky J, Wang Y, Chang MJ, Thomas C, Hockstein S, Lipner SR. Nail Changes during Pregnancy: A Cross-Sectional Survey of Patients at an Academic Center. Skin Appendage Disord. 2023 Jan;9(1):27-29. [PMC free article: PMC9833000] [PubMed: 36643198]
60.
Mendes N, Alves PJ, Barros M, Rodrigues JM, Machado J. A Narrative Review of Current Striae Treatments. Healthcare (Basel). 2022 Dec 17;10(12) [PMC free article: PMC9777947] [PubMed: 36554088]

Disclosure: Vithura Kunarathnam declares no relevant financial relationships with ineligible companies.

Disclosure: Karen Carlson declares no relevant financial relationships with ineligible companies.

Copyright © 2026, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

Bookshelf ID: NBK555904PMID: 32310364

Views

  • PubReader
  • Print View
  • Cite this Page

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...